Search Results

You are looking at 1 - 6 of 6 items for

  • Author or Editor: Anitha Vijayan x
  • Refine by Content Type: All x
Clear All Modify Search
Anitha Vijayan

In 2020, acute kidney injury (AKI) came to the forefront during the COVID-19 pandemic as nephrologists struggled to understand the pathophysiology of COVID-19-associated AKI and to provide timely and effective nondialytic and dialytic care to the large volume of patients who overwhelmed healthcare facilities. Recently, personal communications among the members of the ASN COVID-19 Response Team have indicated that the rate of AKI requiring kidney replacement therapy (KRT) in the current wave of the pandemic is lower than that experienced in the spring. The decreasing incidence of severe AKI was also documented in a study of >5000 veterans who were

Anitha Vijayan

Thrombotic microangiopathy (TMA) is an all-encompassing term that is used to describe an occlusive microvascular disease, manifested by microangiopathic hemolytic anemia (MAHA) and thrombocytopenia (Figure 1). Thrombotic thrombocytopenic purpura (TTP) is a rare TMA that typically presents in adulthood and has a worldwide incidence of 1.5-6 cases per million per year. In the United States, the incidence is 2.99 cases per million per year (1). Although TTP is uncommon, it is a devastating disease with high mortality if left untreated and should be considered a clinical emergency. The classical pentad of clinical manifestations (fever, thrombocytopenia, MAHA,

Anitha Vijayan

The COVID-19 pandemic and kidney involvement constitute an evolving story with various twists and turns, and we expect new challenges as we enter the third year of the pandemic. In spring and summer of 2020, COVID-19-associated acute kidney injury (AKI) was one of the biggest challenges in hospitals, as physicians and staff dealt with a surge of COVID-19 patients on the wards and in the intensive care units (ICUs). The incidence of COVID-19-associated AKI in ICUs ranged from 61% to 76% in the United States, with approximately 30% of ICU patients needing kidney replacement therapy (KRT) (1). Patients

Anitha Vijayan and on behalf of Nephrologists Transforming Dialysis Patient Safety

Imagine this scenario as a nephrologist.

Your patient with ESRD undergoing hemodialysis has newly diagnosed hepatitis C virus (HCV) infection. In addition to addressing the immediate medical issue, what is the next course of action? What are the reporting requirements for a new case of HCV infection? Are you required to report this case to state and federal public health agencies? How do you ensure your patient did not acquire the infection due to lapses in infection prevention and control measures at the dialysis facility?

This series of questions may not be at the forefront in the minds of nephrologists

Jorge Cerdá, Samir M. Parikh, Jay Koyner, Anitha Vijayan, Erin Barreto, and on behalf of the initiative

In hospitals and in the community, the incidence of acute kidney injury (AKI) is high and rising worldwide. At the societal level, AKI is increasingly recognized as a major public health burden (1). For the individual patient, severe AKI is a life-altering event with profound immediate and future consequences. Recently, the COVID-19 pandemic has highlighted the impact of AKI in hospitalized patients with SARS-CoV-2 infection.

AKI is not a single disease, but a syndrome caused by multiple mechanisms in patients with different comorbidities and several potential treatment targets. By developing the AKI!Now initiative, ASN is committed

Anitha Vijayan MD FASN Alan Kliger MD Eileen McHale BSN RN Susan Stark Darlene Rodgers BSN RN CNN CPHQ and Bonnie Freshly MEd CMP

Registration is now open for the third webinar in the Nephrologists Transforming Dialysis Safety (NTDS) webinar series!

Join your colleagues on March 29 from 12:00 – 1:00 PM EDT.  Registration is free and open to the full dialysis care team, including nephrologists, medical directors, nurse managers, nurses, and technicians.  CME and CEU credit will be available at the conclusion of the webinar.